Radiological Clues to Differentiate Benign Mastitis from Breast Cancer
    PDF
    Cite
    Share
    Request
    Invited Review
    P: 258-269
    December 2023

    Radiological Clues to Differentiate Benign Mastitis from Breast Cancer

    Trd Sem 2023;11(3):258-269
    1. Trakya Üniversitesi Tıp Fakültesi, Radyoloji Anabilim Dalı, Edirne, Türkiye
    No information available.
    No information available
    Received Date: 25.10.2023
    Accepted Date: 27.11.2023
    Publish Date: 21.12.2023
    PDF
    Cite
    Share
    Request

    ABSTRACT

    Inflammatory breast disease is an entity that commonly includes different pathologies such as infectious, non-infectious and malignant inflammation. Non-lactational mastitis and inflammatory breast cancer are clinically similar, and imaging methods have great importance in diagnostic distinction. By using imaging methods correctly in the diagnosis of benign and malignant inflammation, unnecessary biopsies are minimized. In this review, the advantages and disadvantages of ultrasonography, mammography and magnetic resonance imaging in the diagnostic and treatment management of inflammatory breast lesions due to different reasons are compared and new imaging methods are also mentioned.

    References

    1Leong PW, Chotai NC, Kulkarni S. Imaging features of inflammatory breast disorders: a pictorial essay. Korean J Radiol 2018; 19: 5-14.
    2Trop I, Dugas A, David J, El Khoury M, Boileau JF, Larouche N, et al. Breast abscesses: evidence-based algorithms for diagnosis, management, and follow-up. Radiographics 2011; 31: 1683-99.
    3Mais DD, Kist KA, Nanyes JE, Quintero CJ, Alizai H, Mais DD, et al. Idiopathic granulomatous mastitis: manifestations at multimodality imaging and pitfalls. Radiographics 2018; 38: 330-56.
    4Matich A, Sud S, Buxi TBS, Dogra V. Idiopathic granulomatous mastitis and its mimics on magnetic resonance imaging: a pictorial review of cases from India. J Clin Imaging Sci 2020; 10: 53.
    5Kessler E, Wolloch Y. Granulomatous mastitis: a lesion clinically simulating carcinoma. Am J Clin Pathol 1972; 58: 642-6.
    6Reddy KM, Meyer CE, Nakdjevani A, Shrotria S. Idiopathic granulomatous mastitis in the male breast. Breast J 2005; 11: 73.
    7Al Manasra AR, Al-Hurani MF. Granulomatous mastitis: a rare cause of male breast lump. Case Rep Oncol 2016; 9: 516-9.
    8Lepori D. Inflammatory breast disease: the radiologist’s role. Diagn Interv Imaging. 2015; 96: 1045-64.
    9Martinez-Ramos D, Simon-Monterde L, Suelves-Piqueres C, Queralt-Martin R, Granel-Villach L, Laguna-Sastre JM, et al. Idiopathic granulomatous mastitis: a systematic review of 3060 patients. Breast J 2019; 25: 1245-50.
    10Co M, Cheng VCC, Wei J, Wong SCY, Chan SMS, Shek T, et al. Idiopathic granulomatous mastitis: a 10-year study from a multicentre clinical database. Pathology 2018; 50: 742-7.
    11Yaghan R, Hamouri S, Ayoub NM, Yaghan L, Mazahreh T. A proposal of a clinically based classification for idiopathic granulomatous mastitis. Asian Pac J Cancer Prev 2019; 20: 929-34.
    12Yaghan RJ, Ayoub NM, Hamouri S, Al-Mohtaseb A, Gharaibeh M, Yaghan L, et al. The role of establishing a multidisciplinary team for idiopathic granulomatous mastitis in improving patient outcomes and spreading awareness about recent disease trends. Int J Breast Cancer 2020; 2020: 5243958.
    13[Al-Khawari HA, Al-Manfouhi HA, Madda JP, Kovacs A, Sheikh M, Roberts O. Radiologic features of granulomatous mastitis. Breast J 2011; 17: 645-50.
    14Aghajanzadeh M, Hassanzadeh R, Alizadeh Sefat S, Alavi A, Hemmati H, Esmaeili Delshad MS, et al. Granulomatous mastitis: presentations, diagnosis, treatment and outcome in 206 patients from the north of Iran. Breast 2015; 24: 456-60.
    15[Hovanessian Larsen LJ, Peyvandi B, Klipfel N, Grant E, Iyengar G. Granulomatous lobular mastitis: imaging, diagnosis, and treatment. AJR Am J Roentgenol 2009; 193: 574-81.
    16Alikhassi A, Azizi F, Ensani F. Imaging features of granulomatous mastitis in 36 patients with new sonographic signs. J Ultrasound 2020; 23: 61-8.
    17Tuncbilek N, Karakas HM, Okten OO. Imaging of granulomatous mastitis: assessment of three cases. Breast 2004; 13: 510-4.
    18Zhao Q, Xie T, Fu C, Chen L, Bai Q, Grimm R, et al. Differentiation between idiopathic granulomatous mastitis and invasive breast carcinoma, both presenting with non-mass enhancement without rim-enhanced masses: The value of whole-lesion histogram and texture analysis using apparent diffusion coefficient. Eur J Radiol 2020; 123: 108782.
    19Zhang C, Fan P, Liu P, Zhang Z. Applicable value of dynamic magnetic resonance imaging in the evaluation of granulomatous mastitis surgery. J Modem Med 2012; 22: 86-9.
    20Kang BJ, Lipson JA, Planey KR, Zackrisson S, Ikeda DM, Kao J, et al. Rim sign in breast lesions on diffusion-weighted magnetic resonance imaging: diagnostic accuracy and clinical usefulness. J Magn Reson Imaging 2015; 41: 616-23.
    21Maltez de Almeida JR, Gomes AB, Barros TP, Fahel PE, de Seixas Rocha M. Subcategorization of suspicious breast lesions (BI-RADS category 4) according to MRI criteria: role of dynamic contrast-enhanced and diffusion-weighted imaging. AJR Am J Roentgenol 2015; 205: 222-31.
    22Kanao S, Kataoka M, Iima M, Ikeda DM, Toi M, Togashi K. Differentiating benign and malignant inflammatory breast lesions: Value of T2 weighted and diffusion weighted MR images. Magn Reson Imaging 2018; 50: 38-44.
    23Aslan H, Pourbagher A, Colakoglu T. Idiopathic granulomatous mastitis: magnetic resonance imaging findings with diffusion MRI. Acta Radiol 2016; 57: 796-801.
    24Grimm LJ. Breast MRI radiogenomics: current status and research implications. J Magn Reson Imaging 2016; 43: 1269-78.
    25Xie T, Zhao Q, Fu C, Bai Q, Zhou X, Li L, et al. Differentiation of triple-negative breast cancer from other subtypes through whole-tumor histogram analysis on multiparametric MR imaging. Eur Radiol 2019; 29: 2535-44.
    26Tang Q, Li Q, Xie D, Chu KT, Liu LD, Liao CC et al. An Apparent Diffusion Coefficient Histogram Method Versus a Traditional 2-dimensional measurement method for identifying non-puerperal mastitis from breast cancer at 3.0 T. J Comput Assist Tomogr 2018; 42: 776-83.
    27Edge SB, Compton CC. The American Joint Committee on Cancer: the 7th edition of the AJCC cancer staging manual and the future of TNM. Ann Surg Oncol 2010; 17: 1471-4.
    28Cristofanilli M, Valero V, Buzdar AU, Kau SW, Broglio KR, Gonzalez-Angulo AM, et al. Inflammatory breast cancer (IBC) and patterns of recurrence: understanding the biology of a unique disease. Cancer 2007; 110: 1436-44.
    29van Uden DJP, de Wilt JHW, Meeuwis C, Blanken-Peeters CFJM, Mann RM. Dynamic contrast-enhanced magnetic resonance imaging in the assessment of inflammatory breast cancer prior to and after neoadjuvant treatment. Breast Care (Basel) 2017; 12: 224-9.
    30Chow CK. Imaging in inflammatory breast carcinoma. Breast Dis 2005-2006; 22: 45-54.
    31Nguyen SL, Doyle AJ, Symmans PJ. Interstitial fluid and hypoechoic wall: two sonographic signs of breast abscess. J Clin Ultrasound 2000; 28: 319-24.
    32Guirguis MS, Adrada B, Santiago L, Candelaria R, Arribas E. Mimickers of breast malignancy: imaging findings, pathologic concordance and clinical management. Insights Imaging 2021; 12: 53.
    Article is only available in PDF format. Show PDF
    2024 ©️ Galenos Publishing House